Celebrating Excellence: Colorado's Top CIOs Acknowledged at 2025 ORBIE Awards
July 25, 2025 - 13:02
DENVER, July 24, 2025 — The 2025 Colorado ORBIE Awards have celebrated the outstanding achievements of leading technology executives who have made significant impacts in their organizations. This year, the event honored CIOs from prominent companies including Ball Corporation, Nu Skin Enterprises, CoBank, United Launch Alliance, Denver International Airport, and Ward Electric Company.
The ORBIE Awards, organized by ColoradoCIO—a chapter of the Inspire Leadership Network—recognize CIOs for their leadership, innovation, and the transformative effects they have on business operations. These awards highlight the pivotal role that technology executives play in navigating the complexities of the digital landscape and driving strategic initiatives that foster growth and efficiency.
The event not only serves to honor these leaders but also to inspire the next generation of technology professionals to pursue excellence in their fields. As the tech industry continues to evolve, the contributions of these CIOs will undoubtedly shape the future of their respective organizations and the broader business community.
MORE NEWS
July 25, 2025 - 23:43
Amit Mehra Joins OXON Technologies as Senior Advisor to Boost Climate-Tech InitiativesLONDON, UK – OXON Technologies, a leader in deep-tech innovations aimed at enhancing fuel efficiency and reducing industrial emissions, has announced the appointment of Amit Mehra as Senior...
July 24, 2025 - 18:18
Innovative Surveillance Technology Tracks Individuals via Wi-Fi Signal DisruptionHi-tech surveillance technologies are a double-edged sword. On one hand, there is a desire for sophisticated devices that can detect suspicious behavior and alert authorities. On the other, there...
July 24, 2025 - 02:27
Marvell Technology Positioned for Growth in AI InfrastructureMarvell Technology, Inc. has emerged as a leading player in the AI sector, showcasing significant upside potential. Recently, a prominent financial firm reaffirmed its confidence in Marvell,...
July 23, 2025 - 04:34
FDA Suspends Sarepta's Gene Therapy Designation Amid Safety ConcernsThe FDA has officially revoked the designation for Sarepta’s gene therapy platform technology aimed at treating muscular dystrophy, following a series of patient fatalities linked to its clinical...